Bharati Biotech's Suchitra Ella & Krishna Ella On Covaxin Rollout & Efficacy | Sanjeevani

Shereen Bhan speaks with Bharat Biotech CMD Dr Krishna Ella & Joint MD Suchitra Ella about the concerns regarding Covaxin's approval, efficacy data & more#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #SensexCNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.For latest news and updates visit our Website: https://bit.ly/2YbpXBMSubscribe to our Channel: https://www.youtube.com/user/CNBCTV18Like us on Facebook: https://www.facebook.com/cnbctv18india/Follow us on Twitter: https://twitter.com/CNBCTV18News